4//SEC Filing
RALLIS CHRIS A 4
Accession 0001415889-25-004249
CIK 0001211583other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:13 PM ET
Size
8.9 KB
Accession
0001415889-25-004249
Insider Transaction Report
Form 4
RALLIS CHRIS A
Director
Transactions
- Exercise/Conversion
Common Shares
2025-02-14$2.51/sh+1,992$5,000→ 54,206 total - Sale
Common Shares
2025-02-14$6.82/sh−1,186$8,089→ 53,020 total - Exercise/Conversion
Common Shares
2025-02-14$2.51/sh−1,992$5,000→ 182,706 totalExercise: $2.51From: 2015-03-16Exp: 2025-03-16→ Options (1,992 underlying)
Footnotes (3)
- [F1]Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
- [F2]Shares sold to satisfy tax obligation on option exercise.
- [F3]Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001185945
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:13 PM ET
- Size
- 8.9 KB